cobaltiprotoporphyrin has been researched along with jwh-133 in 1 studies
| Studies (cobaltiprotoporphyrin) | Trials (cobaltiprotoporphyrin) | Recent Studies (post-2010) (cobaltiprotoporphyrin) | Studies (jwh-133) | Trials (jwh-133) | Recent Studies (post-2010) (jwh-133) |
|---|---|---|---|---|---|
| 283 | 0 | 108 | 205 | 1 | 148 |
| Protein | Taxonomy | cobaltiprotoporphyrin (IC50) | jwh-133 (IC50) |
|---|---|---|---|
| Cannabinoid receptor 2 | Homo sapiens (human) | 0.0818 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leánez, S; McDonnell, C; Pol, O | 1 |
1 other study(ies) available for cobaltiprotoporphyrin and jwh-133
| Article | Year |
|---|---|
The Inhibitory Effects of Cobalt Protoporphyrin IX and Cannabinoid 2 Receptor Agonists in Type 2 Diabetic Mice.
Topics: Animals; Blood Glucose; Body Weight; Cannabinoid Receptor Agonists; Cannabinoids; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Models, Animal; Ganglia, Spinal; Heme Oxygenase-1; Hyperalgesia; Male; Mice; Mice, Transgenic; NF-E2-Related Factor 2; Protoporphyrins; Receptor, Cannabinoid, CB2; Sciatic Nerve | 2017 |